BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25963830)

  • 1. A web portal for in-silico action potential predictions.
    Williams G; Mirams GR
    J Pharmacol Toxicol Methods; 2015; 75():10-6. PubMed ID: 25963830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment.
    Elkins RC; Davies MR; Brough SJ; Gavaghan DJ; Cui Y; Abi-Gerges N; Mirams GR
    J Pharmacol Toxicol Methods; 2013; 68(1):112-22. PubMed ID: 23651875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
    Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
    J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
    Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
    Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an in silico cardiac safety assay: using ion channel screening data to predict QT interval changes in the rabbit ventricular wedge.
    Beattie KA; Luscombe C; Williams G; Munoz-Muriedas J; Gavaghan DJ; Cui Y; Mirams GR
    J Pharmacol Toxicol Methods; 2013; 68(1):88-96. PubMed ID: 23624022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced QSAR models for drug-triggered inhibition of the main cardiac ion currents.
    Wiśniowska B; Mendyk A; Szlęk J; Kołaczkowski M; Polak S
    J Appl Toxicol; 2015 Sep; 35(9):1030-9. PubMed ID: 25559930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the venom of the spider Ornithoctonus hainana on neonatal rat ventricular myocytes cellular and ionic electrophysiology.
    Zhang Y; Liu J; Liu Z; Wang M; Wang J; Lu S; Zhu L; Zeng X; Liang S
    Toxicon; 2014 Sep; 87():104-12. PubMed ID: 24930961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of disease state on arrhythmic event detection by action potential modelling in cardiac safety pharmacology.
    Christophe B; Crumb WJ
    J Pharmacol Toxicol Methods; 2019; 96():15-26. PubMed ID: 30580044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cardiac Electrophysiology Web Lab.
    Cooper J; Scharm M; Mirams GR
    Biophys J; 2016 Jan; 110(2):292-300. PubMed ID: 26789753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch-clamp studies of human cardiac ion channels in the evaluation of cardiac electrophysiological effects of compounds.
    Crumb WJ; Cavero I
    Curr Protoc Pharmacol; 2003 May; Chapter 10():Unit10.8. PubMed ID: 21956800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Contributions of Cardiac Ion Channels on Atrial Repolarization and Reentrant Waves: A Multiscale In-Silico Study.
    Sutanto H
    J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three thiadiazinone derivatives, EMD 60417, EMD 66430, and EMD 66398, with class III antiarrhythmic activity but different electrophysiologic profiles.
    Himmel HM; Wettwer E; Lues I; Beier N; Jonas R; Ravens U
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):438-49. PubMed ID: 11486248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-type calcium channel and human ether-a-go-go related gene blockers on the electrical activity of the human heart: a simulation study.
    Zemzemi N; Rodriguez B
    Europace; 2015 Feb; 17(2):326-33. PubMed ID: 25228500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion currents of cardiomyocytes in different regions of the Göttingen minipig heart.
    Arlock P; Mow T; Sjöberg T; Arner A; Steen S; Laursen M
    J Pharmacol Toxicol Methods; 2017 Jul; 86():12-18. PubMed ID: 28254506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lifex-ep: a robust and efficient software for cardiac electrophysiology simulations.
    Africa PC; Piersanti R; Regazzoni F; Bucelli M; Salvador M; Fedele M; Pagani S; Dede' L; Quarteroni A
    BMC Bioinformatics; 2023 Oct; 24(1):389. PubMed ID: 37828428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes.
    Kistamás K; Szentandrássy N; Hegyi B; Ruzsnavszky F; Váczi K; Bárándi L; Horváth B; Szebeni A; Magyar J; Bányász T; Kecskeméti V; Nánási PP
    Eur J Pharmacol; 2013 Jun; 710(1-3):10-9. PubMed ID: 23588116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between Hodgkin-Huxley and Markov formulations of cardiac ion channels.
    Carbonell-Pascual B; Godoy E; Ferrer A; Romero L; Ferrero JM
    J Theor Biol; 2016 Jun; 399():92-102. PubMed ID: 27059892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Dynamic Clamp for Simulation of I
    Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A
    Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.